BAC vs DHR: Which Is the Better Buy?
Side-by-side comparison of Bank of America Corporation and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Bank of America Corporation · Financial Services
$56.20
-45.0% upside to fair value
Grade D
VS
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
BAC trades at a lower forward P/E
(13.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BAC |
DHR |
| Current Price |
$56.20 |
$177.17 |
| Fair Value Estimate |
$30.91 |
$192.90 |
| Upside to Fair Value |
-45.0%
|
+8.9%
|
| Market Cap |
$398.8B |
$125.4B |
| Forward P/E |
13.7x
|
34.1x
|
| EV / EBITDA |
12.8x
|
20.8x
|
| Price / Sales |
2.3x
|
5.1x
|
| Price / FCF |
7.0x
|
23.7x
|
| Revenue Growth YoY |
-35.6%
|
+3.7%
|
| Gross Margin |
63.2%
|
60.7%
|
| Operating Margin |
22.9%
|
21.0%
|
| Return on Equity |
10.5%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
14.18%
|
4.22%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Bank of America Corporation is a large diversified U.S. bank operating across consumer banking, wealth management, global banking, and markets. The company benefits from scale advantages as the second-largest U.S. bank by market capitalization and a broad nationwide footprint with over 213,000 employees. Despite solid profitability metrics including a 10.5% ROE and 18.1% net margin, the stock is …
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Accumulation Zones
| Metric |
BAC |
DHR |
| Zone Low |
$23.18 |
$144.68 |
| Zone High |
$26.27 |
$163.97 |
| In Buy Zone? |
No
|
No
|